Recent studies have shown that pathological lipid accumulation is a characteristic of metabolic diseases, such as type 2 diabetes, nonalcoholic fatty liver disease and the metabolic syndrome [1] [2] [3] . Accumulated lipids in organs can interfere with the insulin sig naling pathway [4] [5] [6] and consequently decrease the amount of glu cose taken up from the bloodstream. This state is referred to as insulin resistance, and it characterizes over 90% of type 2 diabetes patients 1 . Insulin resistance first appears in cells and tissues with important functions for glucose handling, such as liver, muscle and the endothelium [7] [8] [9] . White adipose tissue also develops insu lin resistance and releases large amounts of free fatty acids, which accumulate in the peripheral tissues, further enhancing this vicious cycle 9, 10 . Therefore, to understand the disease progression and the overall metabolic status of an animal or individual, it is crucial to determine the level of lipid accumulation in organs such as liver and muscle. Although the reasons for hepatic lipid accumulation have been debated 11 , it is well accepted that liver and muscular steatosis are tightly connected to insulin resistance and metabolic disease 12 . Thus, more research is needed to understand the exact mechanisms of lipidinduced metabolic dysfunction, highlighting the need for lipidstaining techniques that can be easily adopted and performed in most laboratories. Furthermore, techniques that visualize the morphology and the intracellular localization of LDs within tissues are important for the understanding of general lipid biology.
At present, there are only a few techniques that detect both the amount and the localization of lipids within tissues. Lipid uptake and transport into organs can be assessed in animals in vivo by injecting radioactively labeled lipid tracers such as oleic acid 13 . So far, there are no commercially available fluorescently labeled lipids that can be used in animal models and that, in parallel, show lipid localization and uptake. Fluorescent lipid stains such as BODIPY (4,4difluoro 4bora3a,4adiazasindacene) and Nile red have been used to ana lyze the amount of LDs in tissue sections, mostly in liver and skeletal muscle [14] [15] [16] [17] . One drawback of using BODIPY on cardiac tissue sec tions is the strong autofluorescence of the muscle fibers. The total amount of triglycerides and other lipid species in the tissue can be quantified by lipid extraction followed by thin layer chromatography, mass spectrometry or commercially available enzymatic kits 18, 19 . Apart from being expensive, most of these techniques often demand special equipment and the use of radioactively labeled agents.
We have developed a protocol to detect and analyze neutral lipids based on the lysochrome ORO (C 26 H 24 N 4 O). ORO is a fat soluble diazol dye, with a maximum absorption at 518 nm, which stains neutral lipids and cholesteryl esters but not biological mem branes 20 . The principle for staining is that ORO is minimally solu ble in the solvent, and the solubility is further decreased by dilution of ORO in water before use. The hydrophobic dye will therefore move from the solvent to associate with the lipids within tissue sections. ORO has been found to be the most accurate method for detecting and quantifying hepatic steatosis both in mouse and human liver biopsies 21, 22 . Furthermore, ORO staining assays on human muscle biopsies have also been reported 23, 24 . However, the handling of tissues and the procedures during ORO staining in these studies varies to a great extent 14, 22 .
Here we present an ORO staining protocol that enables staining of several different tissues. This protocol entails optimizing fixation requirements and handling of sensitive tissues such as skeletal muscle, and it provides advice on the section thickness and the incubation time with ORO, as well as on choosing mounting medium, micro scopic acquisition and data image analysis. By using three independent observers, the relative s.d. of the quantification analysis integrated in the current protocol is 2%, thus showing great robustness of the method. This protocol is compatible with ORO analysis of multi ple tissue sections both from normal and metabolically challenged animals. It also allows the detection of accumulated LDs and their intra cellular localization in various tissues. ORO analysis is inexpensive and requires only basic laboratory equipment, and even larger data sets are easily quantifiable with standard computerbased software 2, 13 . As an example to show the usefulness of our protocol, Figure 1 includes images obtained from different obese and insulinresistant mouse models, showing the anticipated results in skeletal muscle, heart and liver. We have used the protocol described here in our recent work in order to quantify muscular and liver lipid accumulation during both physiological 13 and pathological 2 conditions.
Limitations
Some limitations exist with ORO staining mainly with regard to staining of differ ent lipid species and tissue preparation. By performing ORO staining, different lipid species within LDs cannot be distinguished. LDs consist of a core of neutral lipids surrounded by a layer of polar lipids and proteins 25 . ORO stains only the most hydrophobic and neutral lipids (i.e., triglycerides, diacylglycerols and cholesterol esters), whereas polar lipids (i.e., phospholipids, sphingolipids and ceramides) are not stained 17 . Therefore, ORO staining cannot be used to quantify the accumula tion of specific lipid species within the tissue. Caution should be taken while using ORO in fine structural analysis of LD morphol ogy, as ORO staining of hepatocytes in vitro showed that alcohol based solvent or mounting medium caused fusion of adjacent LDs in fixed samples 26 . Paraffinembedded tissues and alcohol based fixatives cannot be used for this staining procedure, as the deparaffinization process and alcohol fixation extract most lipids from the tissue sections. This excludes the use of ORO staining in sections from white and brown adipose tissues, as these tissues demand paraffinization and/or rigid fixation to preserve tissue morphology. Tissues with low endogenous lipid accumulation, such as pancreas, can also be difficult to stain with ORO. Finally, quantification with some software can be timeconsuming, as larger data sets are required to obtain correct quantification. We therefore recommend optimizing imaging software to include automatic quantification scripts.
Experimental design
When you are planning the experiment, controls should be used according to good laboratory practice. It is recommended to include lean controls in the experiment, especially when you are analyzing animal models that have been metabolically challenged. A lean control refers to an animal that is inherently lean and has been fed a normal diet (ND). The inclusion of a lean control is of importance specifically when the control group in an experiment is not normal, e.g., in adenoviral genetransfer studies, in which the control vectors contain GFP or βgalactosidase. In general, a minimum of five animals per group should be used.
For optimal results with this protocol, special care is needed, mainly during the collection of tissues. We obtain the best results with non fixed tissue material. As mentioned above, alcoholbased fixatives should be avoided, as they extract lipids from the tissue. However, the protocol can be adapted to include an additional step of brief paraformaldehyde fixation. During tissue collection, it is crucial to freeze the dissected tissues as quickly as possible. This is best achieved by submersing them directly into liquid nitrogen (liquid N 2 ). If liquid N 2 is unavailable, a dry ice and isopropanol bath can be used. Tissues should subsequently be stored at − 80 °C, and they should not be thawed either before sectioning or during embedding, as this will cause loss of tissue integrity and, consequently, inaccurate ORO stain ing. The TROUBLESHOOTING section includes more details on how to preserve tissue integrity. To obtain an overview of intratissue lipid accumulation, a minimum of three sections from different depths of the tissue should be collected during sectioning. For correct quantifi cation, a sufficient number of images per subject should be included, and it is important to avoid nonspecific staining, dye precipitation or sections with damaged tissue morphology. If images with such areas are obtained and are necessary for the analysis, software tools that can exclude these nonspecific stained areas should be used. The TROUBLESHOOTING section includes examples and solutions.
Our protocol represents a valuable tool in several research fields in which lipid transport and lipid accumulation are of importance. The protocol can, for example, be easily adapted for staining of athero sclerotic plaques or for the determination of lipid content in tumor cells 27, 28 . For tissues not mentioned in this protocol, we still recom mend that you start by testing the protocol described here. One of the most crucial steps when you are using this staining method is to obtain samples in which the integrity of the tissue is intact; hence, a possible optimization should first deal with tissue handling and sec tioning. When an intact morphology is obtained, the ORO incuba tion time can be optimized by starting from 5 min and adjusting the time according to the desired staining intensity. We recommend not exceeding 30 min of ORO incubation because of dye precipitation. Visualization and quantification of neutral lipids by ORO analysis in skeletal muscle, heart and liver sections from mice on ND, HFD and from db/db mice. Scale bars, 100 µm; magnification is ×40 for skeletal muscle and ×20 for heart and liver; n = 3-4 per group. Insets from the images are magnified five times in order to highlight the lipid-staining morphology. a.u., arbitrary units. *P < 0.05, **P < 0.01, ***P < 0.001 compared with lean mice. Values are means ± s.e.m. 4| Section the tissue and collect three cross-sections from different depths of the organ onto the same glass slide in order to provide a good overview of the tissue. In general, we use 12-µm-thick sections for most organs.  crItIcal step To avoid detachment of the sections during the ORO staining procedure, let the sections dry for 10 min at RT before freezing them.  pause poInt The sections can be stored at − 80 °C for up to 3 years.
oro staining • tIMInG 2 h in total 5|
Prepare ORO stock and working solution as specified in Reagent Setup.
6| If the sections have been stored at − 80 °C, allow them to equilibrate for 10 min at RT.
7|
Trace the area around the sections by using a liquid blocker pen.
8| Add ~1 ml of ORO working solution to cover the sections.  crItIcal step The sections need to be completely covered by solution during the staining procedure; otherwise, the ORO stain will dry and become uneven.
9| Incubate the sections with ORO working solution at RT. The duration of the incubation depends on the tissue and the animal model or subject. As a guideline, we use an incubation time of 5 min with the ORO solution for heart and liver sections and a time of 10 min for muscle sections.
10| (Optional) Counterstain the sections with Mayer′s hematoxylin by submerging the sections in hematoxylin for 15 s, and thereafter dipping the sections into the lithium solution three times. This step visualizes the cell nuclei and tissue morphology, but it can interfere with the lipid quantification.
11| Rinse the sections under running tap water for ~30 min. Take care that the sections are not harmed during rinsing. This is best done by placing the sections in a slide holder and facing the biopsies away from the running water.
12| (Optional) Check the sections by using a light microscope for a quick analysis to ensure sufficient staining and washing. If insufficient staining is observed, go back to Step 9 and repeat the staining procedure.
13|
Mount the slides with a water-soluble mounting medium and place coverslips on them. Let the mounting medium set for 10 min at RT and then seal the coverslip edges with nail polish, making them airtight.  pause poInt The mounted slides can be left at RT for a maximum of 24 h.
acquisition and quantification of images
• tIMInG 2-6 h 14| Capture bright-field images with a light microscope; we suggest using magnifications of ×20 for heart and liver and ×40 for muscles. The background is corrected by white balance and is selected as a blank area outside the section. A minimum of ten frames per biopsy is required for data image analysis and correct quantification. The exact number of frames can, however, vary depending on the heterogeneity within the group.  crItIcal step The stained sections should be photographed within 24 h to avoid precipitation of the ORO dye.
? trouBlesHootInG
15|
Quantify tissue lipid accumulation via the amount of ORO staining by using standard quantification software supplied within the microscope software package (e.g., for Zeiss microscopes, Axiovision and Velocity) or by image-dedicated software (e.g., ImageJ or Fiji). The most robust and reproducible estimate of ORO staining is obtained by using pixel number as the quantitative measurement. The intensity of the ORO staining of the LDs can also be used. However, measurements based on the intensity can give inaccurate results in tissues with large LDs with irregular intensity, such as in the liver. Below, we provide instructions for lipid quantification in detail for Zeiss automatic quantification program Axiovision (option A) and the free-of-charge program ImageJ (option B) 29 . To maintain as much information in the acquired images as possible, we prefer using the software supplied with the microscope. (a) Quantification in axiovision (i) Design an automatic program file that calculates the amount of red pixels in relation to µm 2 of the section area. To do this, choose the image with the highest ORO staining that is included in the analysis. Use the Run Wizard tool to set the pixel threshold according to that image and your requirements. (ii) Conduct a test run by using the Run Analysis tool on images with high, medium and low ORO staining, and verify correct quantification. (iii) When a good program file has been designed, it can be used to quantify all the images from the same ORO experiment by using the Run Analysis tool. If necessary, remove the damaged tissue areas or nonspecific staining from an image, easiest done by restricting the area of quantification with the Select Area tool. Results are obtained as densitometric count (pixels squared) and image area (µm 2 ). Results are obtained by running the Analyze → Measure tool. The Area value is the size of the selection within the set threshold. Integrated density gives two results: IntDen, which is the product of Area and Mean gray value, and RawIntDen, which represents the sum of all values of all pixels in the selection. (iv) To achieve the optimal settings, perform this procedure with images of high, medium and low ORO staining. (v) For processing large data sets, the ImageJ software offers a batch tool. To make use of this tool, create a macro for the above-generated procedure by using the Plugins → Macro → Record tool. This macro can then be used with the Process → Batch → Macro tool, and all images in the chosen folder will be analyzed within a few seconds.
16| Evaluate the data in terms of staining and quantification. For all quantification procedures, we highly recommend proofreading the generated results and visually controlling those images that give outlier measurement, e.g., nonspecific staining, which has to be excluded from the selection. Data from every image can be analyzed in programs such as Microsoft Excel. Calculations of significance should be performed according to the material and the group analyzed.
? trouBlesHootInG Troubleshooting advice can be found in table 1. The images in the table show ORO staining of soleus muscle sections, illustrating possible tissue handling and staining problems such as ORO dye precipitation, damaged tissue section and nonspecific ORO staining (scale bar, 100 µm; magnification is ×40 ). Insets from the images are magnified ten times in order to highlight the characteristics of the problem.
• tIMInG Steps 1 and 2, collection of material: 1-6 h, depending on the number of subjects and different tissues
Step 3 and 4, sectioning of material: 1-6 h, depending on the number of subjects and tissues Steps 5-13, ORO staining: 2 h in total Steps 14-16, acquisition and quantification of images: 2-6 h, depending on the number of subjects and tissues
antIcIpateD results
Our protocol for ORO analysis can successfully be used for imaging and quantification of neutral lipids within a tissue, as well as to compare abundance, morphology, localization and size of the LDs within and between organs (Fig. 1) .
In skeletal muscles from ND-fed mice, staining of LDs with ORO results in a mosaic pattern of muscle fibers, illustrating the two major muscle fiber types: type I and type II fibers. Type I oxidative muscle fibers have markedly higher ORO staining than the glycolytic type II fibers. Staining of cardiac muscle from ND mice demonstrates the appearance of sparse, small, spherical LDs in close proximity to the sarcolemma. Hepatocytes store neutral lipids in large, irregularly shaped fat vacuoles (liposomes) around the centrally located nucleus (Fig. 1) . Lipids can also be stored in hepatic stellate cells, which contain vitamin A esters, although the function of the stellate cells in metabolic diseases is not clear 30 . Our protocol has been optimized to evaluate the lipid accumulation in mouse models of obesity, diabetes and the metabolic syndrome. Muscular and liver ORO analyses of HFD-fed, insulin-resistant mice show an increase of three-and ninefold in intratissue lipid accumulation, respectively, as compared with ND-fed mice. After HFD, skeletal muscle lipid accumulation is increased throughout all muscle fiber types and in the surrounding sarcolemma. In cardiomyocytes, the LDs increase both in number and in size in HFD-compared with ND-fed mice. In hepatocytes, the liposomes fill up with lipids, thus increasing markedly in size. In genetically induced obese and diabetic mice (db/db), the lipid accumulation is further increased, showing an 8-, 7-and 15-fold increase in muscle, heart and liver, respectively, as compared with ND control mice (Fig. 1) . In hepatocytes from db/db mice, accumulated lipids fill and expand the liposome to the extent that the nuclei are forced to the side of the cells, a characteristic morphological feature of fatty liver. Thus, ORO staining efficiently helps to visualize the radical changes that occur in tissues as metabolic disease occurs and progresses.
Taken together, the protocol for neutral lipid visualization described here can be used as an efficient tool for determining the whole-body metabolic status of the individual, and it can serve as the basis for further studies. autHor contrIButIons A.M. performed in vivo mouse experiments, ORO analyses and wrote the paper; C.E.H. optimized the protocol and commented on the paper; L.M. commented on the paper; U.E. commented on the paper; A.F. optimized the protocol, performed ORO analyses, assisted in in vivo mouse studies and wrote the paper. All the authors discussed the results and commented on the manuscript.
